Brief: Shanghai Haohai Biological Technology Co enters into equity transfer agreement
15/11/2016 22:07
Nov 16 (Reuters) - Shanghai Haohai Biological Technology Co
Ltd 6826.HK
* Shanghai haohai biological technology co ltd - deal for
consideration of rmb360 million
* Shanghai haohai biological technology - sellers agreed to
sell 60% equity interest in a shenzhen ophthalmology products
trading company to co
* Company and sellers entered into equity transfer agreement
* Shanghai haohai biological technology-consideration will
be funded by proceeds raised from initial public offering of
group in april 2015
Source text for Eikon: ID:nHKS7YwgDv
Further company coverage: 6826.HK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.